Australia Pharmacogenetics Testing in Psychiatry/Depression Market (2025-2031) | Forecast, Share, Value, Size & Revenue, Analysis, Industry, Competitive Landscape, Growth, Companies, Outlook, Segmentation, Trends

Name: Australia Pharmacogenetics Testing in Psychiatry/Depression Market (2025-2031) | Forecast & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (Anxiety, Mood Disorders, Depression, Bipolar Disorders, Psychotic Disorders, Eating Disorders), By Test Type (Whole Genome Sequencing, Chromosomal Array-Based Tests), By Gene Type (CYP2C19, CYP2C9 AND VKORC1, CYP2D6, HLA-B, HTR2A/C, HLA-A, CYP3A4), By Patient Type (Child, Adult, Geriatric), By Product (Instruments, Consumables, Software & Services), By End User (Hospitals & Clinics, Dignostics Laboratories, Academic And Research Institutes, Others), By Distribution Channel (Direct Tender, Third-Party Distribution, Hospital Pharmacy, Others) And Competitive Landscape

Product Code: ETC6188170	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Australia Pharmacogenetics Testing In Psychiatrydepression Market Overview

Within psychiatric care, pharmacogenetics testing is increasingly used in Australia to guide antidepressant and antipsychotic therapy. Mental health providers are adopting genetic testing to optimize drug selection, particularly for treatment-resistant depression. The market is benefiting from growing mental health awareness, clinician education, and private healthcare investment.

Trends of the market

Trends in this niche market are focused on enhancing treatment outcomes in mental health. Australia is witnessing a gradual integration of pharmacogenetic testing in psychiatry to guide antidepressant selection and dosage. Mental health practitioners are increasingly adopting these tests to minimize trial-and-error prescribing and reduce side effects.

Challenges of the market

The integration of genetic testing into mental health treatment remains low due to skepticism among psychiatrists and limited clinical evidence. Patient reluctance to undergo genetic testing, ethical concerns, and regulatory scrutiny regarding data use further restrict the markets expansion.

Investment opportunities in the Market

Investors in mental health-focused pharmacogenetic testing are supported by dedicated mental health budget allocations and personalized medicine research funding. Government policies promote integration of pharmacogenetics into mental healthcare frameworks, offering grant-based and institutional support for companies engaged in psychiatric pharmacogenomic innovation.

Government Policy of the market

Recognizing the potential of personalized mental health treatments, government policies encourage research and clinical validation of pharmacogenetic testing in psychiatry. The Medical Research Future Fund (MRFF) has supported studies on mental health genetics, and guidelines are being developed to promote the responsible use of these tests in psychiatric care settings, particularly for depression treatment.

Key Highlights of the Report:

Australia Pharmacogenetics Testing in Psychiatry/Depression Market Outlook
Market Size of Australia Pharmacogenetics Testing in Psychiatry/Depression Market, 2024
Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market, 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Revenues & Volume for the Period 2021- 2031
Australia Pharmacogenetics Testing in Psychiatry/Depression Market Trend Evolution
Australia Pharmacogenetics Testing in Psychiatry/Depression Market Drivers and Challenges
Australia Pharmacogenetics Testing in Psychiatry/Depression Price Trends
Australia Pharmacogenetics Testing in Psychiatry/Depression Porter's Five Forces
Australia Pharmacogenetics Testing in Psychiatry/Depression Industry Life Cycle
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Anxiety for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Mood Disorders for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Depression for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Bipolar Disorders for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Psychotic Disorders for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Eating Disorders for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Test Type for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Whole Genome Sequencing for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Chromosomal Array-Based Tests for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Gene Type for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By CYP2C19 for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By CYP2C9 AND VKORC1 for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By CYP2D6 for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By HLA-B for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By HTR2A/C for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By HLA-A for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By CYP3A4 for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Patient Type for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Child for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Adult for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Geriatric for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Instruments for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Consumables for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Software & Services for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Hospitals & Clinics for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Dignostics Laboratories for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Academic And Research Institutes for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Direct Tender for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Third-Party Distribution for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
Historical Data and Forecast of Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume By Others for the Period 2021- 2031
Australia Pharmacogenetics Testing in Psychiatry/Depression Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Test Type
Market Opportunity Assessment By Gene Type
Market Opportunity Assessment By Patient Type
Market Opportunity Assessment By Product
Market Opportunity Assessment By End User
Market Opportunity Assessment By Distribution Channel
Australia Pharmacogenetics Testing in Psychiatry/Depression Top Companies Market Share
Australia Pharmacogenetics Testing in Psychiatry/Depression Competitive Benchmarking By Technical and Operational Parameters
Australia Pharmacogenetics Testing in Psychiatry/Depression Company Profiles
Australia Pharmacogenetics Testing in Psychiatry/Depression Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, 2021 & 2031F

3.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market - Industry Life Cycle

3.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market - Porter's Five Forces

3.5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Test Type, 2021 & 2031F

3.7 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Gene Type, 2021 & 2031F

3.8 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Patient Type, 2021 & 2031F

3.9 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Product, 2021 & 2031F

3.10 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By End User, 2021 & 2031F

3.11 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about personalized medicine and genetic testing in psychiatry

4.2.2 Growing demand for more effective and personalized treatment options for depression

4.2.3 Supportive government initiatives and policies promoting pharmacogenetics testing in healthcare

4.3 Market Restraints

4.3.1 High costs associated with pharmacogenetics testing procedures

4.3.2 Limited insurance coverage for genetic testing in psychiatry/depression

4.3.3 Concerns regarding data privacy and ethical issues surrounding genetic testing

5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Trends

6 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By Types

6.1 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By Type

6.1.1 Overview and Analysis

6.1.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Anxiety, 2021- 2031F

6.1.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Mood Disorders, 2021- 2031F

6.1.5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Depression, 2021- 2031F

6.1.6 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Bipolar Disorders, 2021- 2031F

6.1.7 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Psychotic Disorders, 2021- 2031F

6.1.8 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Eating Disorders, 2021- 2031F

6.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By Test Type

6.2.1 Overview and Analysis

6.2.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.2.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Chromosomal Array-Based Tests, 2021- 2031F

6.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By Gene Type

6.3.1 Overview and Analysis

6.3.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2C19, 2021- 2031F

6.3.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2C9 AND VKORC1, 2021- 2031F

6.3.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2D6, 2021- 2031F

6.3.5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HLA-B, 2021- 2031F

6.3.6 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HTR2A/C, 2021- 2031F

6.3.7 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HLA-A, 2021- 2031F

6.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By Patient Type

6.4.1 Overview and Analysis

6.4.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Child, 2021- 2031F

6.4.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Adult, 2021- 2031F

6.4.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Geriatric, 2021- 2031F

6.5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By Product

6.5.1 Overview and Analysis

6.5.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Instruments, 2021- 2031F

6.5.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Consumables, 2021- 2031F

6.5.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Software & Services, 2021- 2031F

6.6 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By End User

6.6.1 Overview and Analysis

6.6.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.6.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Dignostics Laboratories, 2021- 2031F

6.6.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Academic And Research Institutes, 2021- 2031F

6.6.5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F

6.7 Australia Pharmacogenetics Testing in Psychiatry/Depression Market, By Distribution Channel

6.7.1 Overview and Analysis

6.7.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Direct Tender, 2021- 2031F

6.7.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Third-Party Distribution, 2021- 2031F

6.7.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F

6.7.5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F

7 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Import-Export Trade Statistics

7.1 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Export to Major Countries

7.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Imports from Major Countries

8 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Key Performance Indicators

8.1 Number of psychiatrists and healthcare providers offering pharmacogenetics testing services

8.2 Adoption rate among patients for pharmacogenetics testing in psychiatry/depression

8.3 Research and development investments in new testing technologies for personalized treatment options

9 Australia Pharmacogenetics Testing in Psychiatry/Depression Market - Opportunity Assessment

9.1 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Test Type, 2021 & 2031F

9.3 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Gene Type, 2021 & 2031F

9.4 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Patient Type, 2021 & 2031F

9.5 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Product, 2021 & 2031F

9.6 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By End User, 2021 & 2031F

9.7 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 Australia Pharmacogenetics Testing in Psychiatry/Depression Market - Competitive Landscape

10.1 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Revenue Share, By Companies, 2024

10.2 Australia Pharmacogenetics Testing in Psychiatry/Depression Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Pharmacogenetics Testing in Psychiatry/Depression Market

Argentina Pharmacogenetics Testing in Psychiatry/Depression Market

Brazil Pharmacogenetics Testing in Psychiatry/Depression Market

Cambodia Pharmacogenetics Testing in Psychiatry/Depression Market

Chile Pharmacogenetics Testing in Psychiatry/Depression Market

China Pharmacogenetics Testing in Psychiatry/Depression Market

Global Pharmacogenetics Testing in Psychiatry/Depression Market

Middle East Pharmacogenetics Testing in Psychiatry/Depression Market

North America Pharmacogenetics Testing in Psychiatry/Depression Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here